Cite
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
MLA
Wang, Meihua, et al. “Are Tumor Size Changes Predictive of Survival for Checkpoint Blockade Based Immunotherapy in Metastatic Melanoma?” Journal for ImmunoTherapy of Cancer, vol. 7, no. 1, Feb. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1186/s40425-019-0513-4.
APA
Wang, M., Chen, C., Jemielita, T., Anderson, J., Li, X. (Nicole), Hu, C., Kang, S. P., Ibrahim, N., & Ebbinghaus, S. (2019). Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma? Journal for ImmunoTherapy of Cancer, 7(1), N.PAG. https://doi.org/10.1186/s40425-019-0513-4
Chicago
Wang, Meihua, Cong Chen, Thomas Jemielita, James Anderson, Xiaoyun (Nicole) Li, Chen Hu, S. Peter Kang, Nageatte Ibrahim, and Scot Ebbinghaus. 2019. “Are Tumor Size Changes Predictive of Survival for Checkpoint Blockade Based Immunotherapy in Metastatic Melanoma?” Journal for ImmunoTherapy of Cancer 7 (1): N.PAG. doi:10.1186/s40425-019-0513-4.